FOXM1 and gastric cancer: In order to increase the bioavailability of genistein, 7-difluoromethoxyl-5,4′-di-n-octylygenistein (DFOG) was synthesized and this compound was shown to downregulate FOXM1 expression in EOC [284,360] and gastric cancer [361] cells.